March 1, 2024 07:04 AM EST
People
Peer Review

Pfiz­er names a VC leader in year of re­set; For­mer Ax­cel­la CEO moves on af­ter com­pa­ny shut­down

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ A spokesper­son for Pfiz­er tells Peer Re­view that Michael Diem has joined the phar­ma gi­ant as head of ven­ture cap­i­tal & eq­ui­ty in­vest­ments. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times